These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. Delineation of gross tumor volume (GTV) for radiation treatment planning of locally advanced rectal cancer using information from MRI or FDG-PET/CT: a prospective study. Brændengen M; Hansson K; Radu C; Siegbahn A; Jacobsson H; Glimelius B Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e439-45. PubMed ID: 21641122 [TBL] [Abstract][Full Text] [Related]
33. Comparison of Coregistration Accuracy of Pelvic Structures Between Sequential and Simultaneous Imaging During Hybrid PET/MRI in Patients with Bladder Cancer. Rosenkrantz AB; Balar AV; Huang WC; Jackson K; Friedman KP Clin Nucl Med; 2015 Aug; 40(8):637-41. PubMed ID: 25783514 [TBL] [Abstract][Full Text] [Related]
34. Coregistered whole body magnetic resonance imaging-positron emission tomography (MRI-PET) versus PET-computed tomography plus brain MRI in staging resectable lung cancer: comparisons of clinical effectiveness in a randomized trial. Yi CA; Lee KS; Lee HY; Kim S; Kwon OJ; Kim H; Choi JY; Kim BT; Hwang HS; Shim YM Cancer; 2013 May; 119(10):1784-91. PubMed ID: 23423920 [TBL] [Abstract][Full Text] [Related]
35. [Comparison of high resolution whole-body MRI using parallel imaging and PET-CT. First experiences with a 32-channel MRI system]. Schmidt GP; Baur-Melnyk A; Tiling R; Hahn K; Reiser MF; Schoenberg SO Radiologe; 2004 Sep; 44(9):889-98. PubMed ID: 15349732 [TBL] [Abstract][Full Text] [Related]
36. Relative Value of Restaging MRI, CT, and FDG-PET Scan After Preoperative Chemoradiation for Rectal Cancer. Schneider DA; Akhurst TJ; Ngan SY; Warrier SK; Michael M; Lynch AC; Te Marvelde L; Heriot AG Dis Colon Rectum; 2016 Mar; 59(3):179-86. PubMed ID: 26855391 [TBL] [Abstract][Full Text] [Related]
37. Local and whole-body staging in patients with primary breast cancer: a comparison of one-step to two-step staging utilizing Kirchner J; Grueneisen J; Martin O; Oehmigen M; Quick HH; Bittner AK; Hoffmann O; Ingenwerth M; Catalano OA; Heusch P; Buchbender C; Forsting M; Antoch G; Herrmann K; Umutlu L Eur J Nucl Med Mol Imaging; 2018 Dec; 45(13):2328-2337. PubMed ID: 30056547 [TBL] [Abstract][Full Text] [Related]
38. Positron Emission Tomography/Magnetic Resonance Imaging for Local Tumor Staging in Patients With Primary Breast Cancer: A Comparison With Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging. Grueneisen J; Nagarajah J; Buchbender C; Hoffmann O; Schaarschmidt BM; Poeppel T; Forsting M; Quick HH; Umutlu L; Kinner S Invest Radiol; 2015 Aug; 50(8):505-13. PubMed ID: 26115367 [TBL] [Abstract][Full Text] [Related]
39. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging. Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400 [TBL] [Abstract][Full Text] [Related]
40. The role of ultrasound in primary workup of cervical cancer staging (ESGO, ESTRO, ESP cervical cancer guidelines). Fischerová D; Cibula D Ceska Gynekol; 2019; 84(1):40-48. PubMed ID: 31213057 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]